NP5.DE
Price:
$13.05
Market Cap:
$271.68M
Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in Bresso, Milano, with a dedicated team of 24 full-time employees. The company's core mission is the discovery and advancement of innovative pharmaceutical products, particularly focusing on new therapies for Central Nervous System (CNS) disorders and pain management. Among its leading candidates, safinamide is currently undergoing Phase III clinical trials for the treatment of Parkinson's disease. Additionally, ralfinamide is being developed as a potential therapy for neuropathic pain. The firm's pipeline further includes a range of projects at various preclinical and clinical development stages, such as HF0220 for ...[Read more]
Industry
Biotechnology
IPO Date
2019-07-04
Stock Exchange
XETRA
Ticker
NP5.DE
According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current Current Ratio is 0.76. This represents a change of -64.68% compared to the average of 2.15 of the last 4 quarters.
The mean historical Current Ratio of Newron Pharmaceuticals S.p.A. over the last ten years is 7.14. The current 0.76 Current Ratio has changed 964.09% with respect to the historical average. Over the past ten years (40 quarters), NP5.DE's Current Ratio was at its highest in in the June 2018 quarter at 18.61. The Current Ratio was at its lowest in in the June 2006 quarter at 0.
Average
7.14
Median
6.89
Minimum
0.68
Maximum
15.40
Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 282.62%
Maximum Annual Current Ratio = 15.40
Minimum Annual Increase = -87.98%
Minimum Annual Current Ratio = 0.68
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 0.76 | -70.78% |
| 2024 | 2.60 | 282.62% |
| 2023 | 0.68 | -87.98% |
| 2022 | 5.65 | -47.62% |
| 2021 | 10.79 | 96.35% |
| 2020 | 5.50 | -32.41% |
| 2019 | 8.13 | -39.45% |
| 2018 | 13.43 | -12.81% |
| 2017 | 15.40 | 82.29% |
| 2016 | 8.45 | 25.13% |
The current Current Ratio of Newron Pharmaceuticals S.p.A. (NP5.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.35
5-year avg
4.10
10-year avg
7.14
Newron Pharmaceuticals S.p.A.’s Current Ratio is less than Medios AG (1.92), less than M1 Kliniken AG (2.82), less than Stratec SE (4.33), less than High Tide Inc. (1.46), less than Formycon AG (2.33), less than Mediclin AG (1.74), less than Zura Bio Limited (19.33), less than DocCheck AG (3.18), less than Geratherm Medical AG (20.26), less than Heidelberg Pharma AG (2.40),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.92 | $322.39M | |
| 2.82 | $346.65M | |
| 4.33 | $221.97M | |
| 1.46 | $188.10M | |
| 2.33 | $353.10M | |
| 1.74 | $193.80M | |
| 19.33 | $204.17M | |
| 3.18 | $60.38M | |
| 20.26 | $14.77M | |
| 2.40 | $123.98M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Newron Pharmaceuticals S.p.A.'s Current Ratio?
How is the Current Ratio calculated for Newron Pharmaceuticals S.p.A. (NP5.DE)?
What is the highest Current Ratio for Newron Pharmaceuticals S.p.A. (NP5.DE)?
What is the 3-year average Current Ratio for Newron Pharmaceuticals S.p.A. (NP5.DE)?
What is the 5-year average Current Ratio for Newron Pharmaceuticals S.p.A. (NP5.DE)?
How does the current Current Ratio for Newron Pharmaceuticals S.p.A. (NP5.DE) compare to its historical average?